| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 11010060 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 229 journal articles in the PubMed database | Email to a friend | | |
| Donshik PC, Pearlman D, Pinnas J, et al.
Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Adv Ther 2000 Mar-Apr; 17(2):94-102.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Whitcup SM, Bradford R, Lue J, et al.
Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2004 Jan; 26(1):29-34.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tinkelman DG, Rupp G, Kaufman H, et al.
Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Surv Ophthalmol 1993 Jul-Aug.:133-40.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tauber J, Raizman MB, Ostrov CS, et al.
A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Ocul Pharmacol Ther 1998 Apr; 14(2):137-45.
Abstract | Full Citation | Find Related Articles | | Yaylali V, Demirlenk I, Tatlipinar S, et al.
Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Acta Ophthalmol Scand 2003 Aug; 81(4):378-82.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Richard C, Trinquand C, Bloch-Michel E
Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Eur J Ophthalmol 1998 Oct-Dec; 8(4):207-16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Verin P, Easty DL, Secchi A, et al.
Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am J Ophthalmol 2001 Jun; 131(6):691-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ballas Z, Blumenthal M, Tinkelman DG, et al.
Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Surv Ophthalmol 1993 Jul-Aug.:141-8.
Abstract | Full Citation | Find Related Articles | | Deschenes J, Discepola M, Abelson M
Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Acta Ophthalmol Scand Suppl 1999; (228):47-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
